51-63-8|Dextroamphetamine sulfate|Benzeneethanamine, alpha-methyl-, (S)-, sulfate (21)|-范德生物科技公司

Dextroamphetamine sulfate

NMR下载 COA and HPLC MSDS下载
names：
Benzeneethanamine, alpha-methyl-, (S)-, sulfate (21)
CAS号：
51-63-8
MDL Number：
MF(分子式)： C18H28N2O4S MW(分子量)： 368.49
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Dextroamphetamine sulfate
英文别名	Dextroamphetamine sulfate; NSC 27104; NSC-27104; NSC27104;
CAS号	51-63-8
Inchi	InChI=1S/2C9H13N.H2O4S/c21-8(10)7-9-5-3-2-4-6-9;1-5(2,3)4/h22-6,8H,7,10H2,1H3;(H2,1,2,3,4)/t2*8-;/m00./s1
InchiKey	PYHRZPFZZDCOPH-QXGOIDDHSA-N
分子式 Formula	C18H28N2O4S
分子量 Molecular Weight	368.49
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Dextroamphetamine sulfate(CAS:51-63-8 ):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Dextroamphetamine sulfate is used to treat ADHD. Dextroamphetamine sulfate was discontinued (DEA controlled substance).
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Ogundele MO, Ayyash HF. Review of the evidence for the management of co-morbid Tic disorders in children and adolescents with attention deficit hyperactivity disorder. World J Clin Pediatr. 2018 Feb 8;7(1):36-42. doi: 10.5409/wjcp.v7.i1.36. eCollection 2018 Feb 8. Review. PubMed PMID: 29456930; PubMed Central PMCID: PMC5803563.

[2]Ghazala S, Bilal J, Ross E, Riaz IB, Kalb B, Herbst KL. Low-Dose d-Amphetamine Induced Regression of Liver Fat Deposits in Dercum Disease. Am J Med. 2018 Jun;131(6):705-708. doi: 10.1016/j.amjmed.2017.12.026. Epub 2018 Jan 31. PubMed PMID: 29355511.

[3] McLaughlin T, Blum K, Steinberg B, Modestino EJ, Fried L, Baron D, Siwicki D, Braverman ER, Badgaiyan RD. Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD. J Behav Addict. 2018 Mar 1;7(1):192-203. doi: 10.1556/2006.6.2017.081. Epub 2018 Jan 10. PubMed PMID: 29316800.

[4] Frankl J, Bose S, Kuo PH. False-Positive Dopamine Transporter Imaging Due to Therapeutic Dextroamphetamine/Amphetamine. J Nucl Med Technol. 2017 Dec 22. pii: jnmt.117.201558. doi: 10.2967/jnmt.117.201558. [Epub ahead of print] PubMed PMID: 29273699.

[5] Ward K, Citrome L. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder. Expert Opin Drug Metab Toxicol. 2018 Feb;14(2):229-238. doi: 10.1080/17425255.2018.1420163. Epub 2018 Jan 4. Review. PubMed PMID: 29258368.

6: Cohen JM, Hernández-Díaz S, Bateman BT, Park Y, Desai RJ, Gray KJ, Patorno E, Mogun H, Huybrechts KF. Placental Complications Associated With Psychostimulant Use in Pregnancy. Obstet Gynecol. 2017 Dec;130(6):1192-1201. doi: 10.1097/AOG.0000000000002362. PubMed PMID: 29112657; PubMed Central PMCID: PMC5709205.7: Fitzpatrick CM, Maric VS, Bate ST, Andreasen JT. Influence of intertrial interval on basal and drug-induced impulsive action in the 5-choice serial reaction time task: Effects of d-amphetamine and (±)-2,5-dimethoxy-4-iodoamphetamine (DOI). Neurosci Lett. 2018 Jan 1;66

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开